Literature DB >> 4974448

[On the induction of an active chronic hepatitis by heterologic soluble liver proteins].

F K Kössling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4974448

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Pathol Anat        ISSN: 0042-6423


× No keyword cloud information.
  8 in total

1.  [Humoral immune reactions on the hepatocellular plasma membrane in the experimental chronic active hepatitis in rabbits (author's transl)].

Authors:  U Hopf; K H Meyer zum Büschenfelde; T Hütteroth
Journal:  Klin Wochenschr       Date:  1976-06-15

2.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

3.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

Review 4.  The role of liver membrane antigens as targets in autoimmune type liver disease.

Authors:  K H Meyer zum Büschenfelde; T H Hütteroth; M Manns; B Möller
Journal:  Springer Semin Immunopathol       Date:  1980-12

5.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

Review 6.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Australia antigen and autoantibodies in chronic hepatitis.

Authors:  T L Vischer
Journal:  Br Med J       Date:  1970-06-20

8.  [Experimental thymitis, myocarditis and polymyositis. A contribution to the pathogenesis of myasthenia gravis Erb].

Authors:  P Griss; K Fahr
Journal:  Arch Kreislaufforsch       Date:  1970 Nov-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.